,108 Thus CD8+ T cell responses to MC38 colon carcinoma tumors are elevated in Ptpn22-/- mice as compared to controls, while PTPN22-deficiency combined with PD-1 checkpoint blockade effectively cleared tumors.107. This evidence concerns the gene PTPN22 and colon carcinoma.